These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 12145848

  • 1. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].
    Couturier D.
    Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848
    [Abstract] [Full Text] [Related]

  • 2. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V, Lipton LR, Cummings C, Eftekhar Sadat AT, Izatt L, Hodgson SV, Talbot IC, Thomas HJ, Silver AJ, Tomlinson IP.
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [Abstract] [Full Text] [Related]

  • 3. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.
    Losi L, Di Gregorio C, Pedroni M, Ponti G, Roncucci L, Scarselli A, Genuardi M, Baglioni S, Marino M, Rossi G, Benatti P, Maffei S, Menigatti M, Roncari B, Ponz de Leon M.
    Am J Gastroenterol; 2005 Oct; 100(10):2280-7. PubMed ID: 16181381
    [Abstract] [Full Text] [Related]

  • 4. Hereditary colorectal cancer syndromes.
    Strate LL, Syngal S.
    Cancer Causes Control; 2005 Apr; 16(3):201-13. PubMed ID: 15947872
    [Abstract] [Full Text] [Related]

  • 5. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.
    Boardman LA, Schmidt S, Lindor NM, Burgart LJ, Cunningham JM, Price-Troska T, Snow K, Ahlquist DA, Thibodeau SN.
    Genes Chromosomes Cancer; 2001 Feb; 30(2):181-6. PubMed ID: 11135435
    [Abstract] [Full Text] [Related]

  • 6. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V, Volikos E, Halford SE, Eftekhar Sadat ET, Popat S, Talbot I, Truninger K, Martin J, Jass J, Houlston R, Atkin W, Tomlinson IP, Silver AR.
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [Abstract] [Full Text] [Related]

  • 7. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
    Friedrich A, Kullmann F.
    Med Klin (Munich); 2003 Dec 15; 98(12):776-82. PubMed ID: 14685680
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
    Bläker H, Sutter C, Kadmon M, Otto HF, Von Knebel-Doeberitz M, Gebert J, Helmke BM.
    Genes Chromosomes Cancer; 2004 Oct 15; 41(2):93-8. PubMed ID: 15287021
    [Abstract] [Full Text] [Related]

  • 10. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.
    Miyaki M, Iijima T, Kimura J, Yasuno M, Mori T, Hayashi Y, Koike M, Shitara N, Iwama T, Kuroki T.
    Cancer Res; 1999 Sep 15; 59(18):4506-9. PubMed ID: 10493496
    [Abstract] [Full Text] [Related]

  • 11. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.
    Koornstra JJ, Rijcken FE, Oldenhuis CN, Zwart N, van der Sluis T, Hollema H, deVries EG, Keller JJ, Offerhaus JA, Giardiello FM, Kleibeuker JH.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 15; 14(7):1608-12. PubMed ID: 16030090
    [Abstract] [Full Text] [Related]

  • 12. Cohorts with familial disposition for colon cancers in chemoprevention trials.
    Burt RW.
    J Cell Biochem Suppl; 1996 Jul 15; 25():131-5. PubMed ID: 9027609
    [Abstract] [Full Text] [Related]

  • 13. [Genetics of colorectal cancer. II. Hereditary background of sporadic and familial colorectal cancer].
    Menko FH, Griffioen G, Wijnen JT, Tops CM, Fodde R, Vasen HF.
    Ned Tijdschr Geneeskd; 1999 Jun 05; 143(23):1207-11. PubMed ID: 10389535
    [Abstract] [Full Text] [Related]

  • 14. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors.
    Aaltonen L, Johns L, Järvinen H, Mecklin JP, Houlston R.
    Clin Cancer Res; 2007 Jan 01; 13(1):356-61. PubMed ID: 17200375
    [Abstract] [Full Text] [Related]

  • 15. Can resistant starch and/or aspirin prevent the development of colonic neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 Study.
    Mathers JC, Mickleburgh I, Chapman PC, Bishop DT, Burn J, Concerted Action Polyp Prevention (CAPP) 1 Study.
    Proc Nutr Soc; 2003 Feb 01; 62(1):51-7. PubMed ID: 12740057
    [Abstract] [Full Text] [Related]

  • 16. Multistep carcinogenesis in colorectal cancers.
    Takami K, Yana I, Kurahashi H, Nishisho I.
    Southeast Asian J Trop Med Public Health; 1995 Feb 01; 26 Suppl 1():190-6. PubMed ID: 8629105
    [Abstract] [Full Text] [Related]

  • 17. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G, Ash C, Hay K, Redston M, Kwong E, Hancock B, Mak T, Kargman S, Evans JF, Gallinger S.
    Cancer Res; 2001 Aug 15; 61(16):6131-6. PubMed ID: 11507063
    [Abstract] [Full Text] [Related]

  • 18. [Familial cancer: recent advances].
    Baba S.
    Gan To Kagaku Ryoho; 1999 May 15; 26(6):735-43. PubMed ID: 10410140
    [Abstract] [Full Text] [Related]

  • 19. Chronic inflammatory bowel disease and cancer.
    Pohl C, Hombach A, Kruis W.
    Hepatogastroenterology; 2000 May 15; 47(31):57-70. PubMed ID: 10690586
    [Abstract] [Full Text] [Related]

  • 20. Mouse models for colorectal cancer.
    Heyer J, Yang K, Lipkin M, Edelmann W, Kucherlapati R.
    Oncogene; 1999 Sep 20; 18(38):5325-33. PubMed ID: 10498885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.